GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Additional Paid-In Capital

U-Neuron Biomedical (ROCO:6973) Additional Paid-In Capital : NT$282.86 Mil(As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Additional Paid-In Capital?


U-Neuron Biomedical's quarterly additional paid-in capital increased from Dec. 2022 (NT$50.94 Mil) to Jun. 2023 (NT$282.86 Mil) but then stayed the same from Jun. 2023 (NT$282.86 Mil) to Dec. 2023 (NT$282.86 Mil).

U-Neuron Biomedical's annual additional paid-in capital declined from Dec. 2021 (NT$94.45 Mil) to Dec. 2022 (NT$50.94 Mil) but then increased from Dec. 2022 (NT$50.94 Mil) to Dec. 2023 (NT$282.86 Mil).


U-Neuron Biomedical Additional Paid-In Capital Historical Data

The historical data trend for U-Neuron Biomedical's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Additional Paid-In Capital Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
6.72 94.45 50.94 282.86

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital 94.45 - 50.94 282.86 282.86

U-Neuron Biomedical Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

U-Neuron Biomedical Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


U-Neuron Biomedical (ROCO:6973) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines